Biological Biomarkers in MOMS Partnership
1 other identifier
observational
20
1 country
1
Brief Summary
The investigators propose to evaluate the potential utility of stress-related biomarkers obtained via dried blood spots (DBS) and retinal scans by collecting new data from mothers and children within the New Haven MOMS Partnership, a well-established community-partnered research setting. The proposed research could greatly advance the application of stress-related biomarkers within community-based research by increasing our understanding of how stress, trauma, and depression influence biology in childhood and adulthood, as measured using minimally-invasive approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 29, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedMarch 12, 2020
March 1, 2020
4.2 years
April 29, 2015
March 11, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Mother-Child Dyads Who Complete Assessments & Biological Samples
Feasibility outcome
End of study (approximately 5 years)
Telomere Length
Telomere length will be measured using an adapted method of the Cawthon Telomere Assay
At baseline-After 90 minutes
Advanced Glycation End Products (AGEs)
AGEs or (advanced glycation endproducts) will be measured using a painless non- invasive retinal scanning device that measures autofluorescence of the crystalline lens of the eye
At baseline-After 90 minutes
Interventions
Anthropomorphic biomarkers including height, weight, heart rate, and blood pressure will be taken for each participating mother and child by a research assistant trained to accurately perform these procedures. Blood spots will be collected in finger stick proficiency, using trigger activated lancets to administer finger sticks. Each participating mothers and child will provide a saliva sample using Oragene DNA saliva collection kits
Eligibility Criteria
Low-income, racially and ethnically diverse, un- or under-employed, biological mothers of children in New Haven. Primary source of recruitment will be the screening/needs assessment from our affiliated MOMS Partnership protocol, however, we will actively respond to inquiries from any preliminarily eligible biological mother in the New Haven community who expresses interest in the study
You may qualify if:
- English-speaking adult mothers (age 21 or older) of at least one biological child mothers must be able to answer three verification questions to confirm they are the biological parent of their child
You may not qualify if:
- Non-english speakers
- Women not able to provide informed consent and with no biological children
- Mothers under the age of 21
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale University
New Haven, Connecticut, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2015
First Posted
May 8, 2015
Study Start
November 1, 2014
Primary Completion
January 1, 2019
Study Completion
November 1, 2019
Last Updated
March 12, 2020
Record last verified: 2020-03